• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed since 1998, when FDA received its first GRAS notice. As of October 17, 2016, the GRAS final rule (81 FR 54960; August 17, 2016) requires a specific format for a GRAS notice. Prior to that date, FDA processed GRAS notices under the framework of the GRAS proposed rule (62 FR 18938; April 17, 1997). Notices received prior to the effective date of the GRAS final rule provide examples for potential notifiers for the types of information that may support a GRAS conclusion. In the inventory, notices follow the requirements for the format and content of a GRAS notice as of the effective date of the GRAS final rule.

The inventory notes what type of response letter the FDA sent in response to the notice. Notifiers often resubmit notices that FDA previously ceased to evaluate at the notifier’s request, and resubmitted notices commonly receive a letter indicating FDA has no questions, after addressing deficiencies. In the inventory, entries for notices that were later resubmitted link to the newer entry in the final column. Newer entries for notices that were resubmitted include a link to the previous submission below the substance name.

Some GRNs that FDA previously ceased to evaluate at the notifier’s request were later resubmitted as a food additive petition. For each of these cases, the GRN detail page links to the food additive petition.

After issuing a response letter, we may issue a subsequent letter as circumstances warrant. The issue dates of any subsequent letters are listed under the column, "Date of add’l correspondence.”

We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Download GRAS Notices data in Microsoft Excel web format Download data from this searchable database in Excel format. If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Search within these results
Records Found: 12 Page 1 of 1
GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
  871
Lactobacillus acidophilus DDS-1 Oct 23, 2019 FDA has no questions (in PDF) (49 kB)
  864
Bacillus coagulans SNZ 1969 spore preparation Feb 6, 2020 FDA has no questions (in PDF) (560 kB)
  844
Algal oil (55% docosahexaenoic acid) from Schizochytrium sp. strain FCC-3204 Oct 18, 2019 FDA has no questions (in PDF) (105 kB)
  843
Algal oil (35% docosahexaenoic acid) from Schizochytrium sp. strain FCC-1324 Oct 18, 2019 FDA has no questions (in PDF) (85 kB)
  781
Alpha-tocopherol (fruit and vegetable derived) Nov 5, 2018 FDA has no questions (in PDF) (1 MB)
  769
Vitamin C (fruit and vegetable derived) Oct 23, 2018 FDA has no questions (in PDF) (72 kB)
  656
Enzyme-modified steviol glycosides Sep 28, 2016 FDA has no questions
  424
C-c-phycocyanin-enriched water extract of the cyanobacterium Arthrospira maxima or Arthrospira platensis, (also known as Spirulina maxima or Spirulina platensis) Dec 6, 2012 FDA has no questions; some uses may require a color additive listing
  341
Quercetin Nov 22, 2010 FDA has no questions; some uses may require a color additive listing
  323
Purified steviol glycosides with rebaudioside A and stevioside as the principal components Jul 9, 2010 FDA has no questions Mar 4, 2011
  318
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni May 15, 2010 FDA has no questions
  298
Silicon dioxide Oct 9, 2009 At the notifier's request, FDA ceased to evaluate this notice
  321

GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
-
-